Topics Signing on Memorandum of Cooperation Between NHMRC of Australia and AMED

2018.10.18Topics

The President of the Japan Agency for Medical Research and Development (AMED), Dr. Makoto Suematsu has decided to sign on the Memorandum of Cooperation (MoC) with the National Health and Medical Research Council of Australia (NHMRC). Dr. Suematsu and NHMRC Chief Executive Officer, Professor Anne Kelso AO, signed the MoC on October 17, 2018, at NHMRC offices in Canberra, Australia.

Prof. Anne Kelso, CEO of the National Health and Medical Research Council of Australia (left) and Dr. Makoto Suematsu, President of AMED (right) shake hands after signing the MOC

The NHMRC is the Australian Government’s lead funding agency for health and medical research. Japan will benefit from Australia’s research experience in cancer, refractory disease, regenerative medicine, precision medicine based on genetic data and clinical trials. NHMRC and AMED are also working together through multilateral international research programs that address infectious, rare and chronic disease. Signing of the MoC will further strengthen collaboration between two agencies and pave the way for joint scientific events. The first of these, a workshop to promote on cancer and infectious disease, will be held during March 2019, and there is scope to promote further collaboration through joint research, researcher exchange and joint seminars and symposiums.

Group picture at the signing of the MOC. Prof. Anne Kelso, CEO of the National Health and Medical Research Council of Australia (first row, center left) and Dr. Makoto Suematsu, President of AMED (first row, center right)

Contact

Division Name Department of International Affairs, Japan Agency for Medical Research and Development
Address 7-1, Otemachi 1-chome, Chiyoda-ku, Tokyo 100-0004, Japan
E-Mail international“AT”amed.go.jp(Replace “AT” with @ to send e-mail.)

Last updated 2018.10.18